Ranibizumab - Latest Advances

Long-term Outcome of Anti-VEGF Treatment in Retinopathy of Prematurity: A 12-Year Follow-Up with Ultra-Widefield Imaging.

Journal: Retinal cases & brief reports

Published: November 25, 2025

DERIVATION OF A SHORT FORM OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Journal: Retina (Philadelphia, Pa.)

Published: November 14, 2025

Characterization of collateral circulation after anti-VEGF treatment for retinal vein occlusion

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: November 11, 2025

Trends in Anti-Vascular Endothelial Growth Factor Injections Among Medicare Part B Beneficiaries in 2013-2021 and the Step Therapy Era.

Journal: Journal of vitreoretinal diseases

Published: November 10, 2025

Fibrosis in Patients With Choroidal Neovascularization Based on Spectral-Domain Optical Coherence Tomography: Findings From the HARBOR Trial.

Journal: Journal of vitreoretinal diseases

Published: November 10, 2025

Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice.

Journal: International journal of retina and vitreous

Published: November 02, 2025

Clinical Challenges with Neovascular Glaucoma-Patient Tailored Strategies and Outcomes.

Journal: Nigerian medical journal : journal of the Nigeria Medical Association

Published: October 31, 2025

Short-Term Effects of Intravitreal Ranibizumab Biosimilar Injections in Patients with Neovascular Age-Related Macular Degeneration on Retinal Nerve Fiber Layer Thickness.

Journal: Journal of clinical medicine

Published: October 22, 2025

A Multicentre Study of Presumed Post Anti Vascular Endothelial Growth Factor Injection Endophthalmitis in Infants with Retinopathy of Prematurity: Clinical Features, Treatment Outcomes, and Review of Literature.

Journal: Ocular immunology and inflammation

Published: October 22, 2025

Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk.

Journal: International journal of retina and vitreous

Published: October 21, 2025

Cost-effectiveness analysis of Brolucizumab compared to Aflibercept and Ranibizumab in nAMD with persistent retinal fluid.

Journal: European journal of ophthalmology

Published: October 21, 2025

Model-based pharmacoeconomic analysis of anti-VEGF strategies for neovascular age-related macular degeneration: a value-based comparison of real-world administration approaches.

Journal: BMJ open

Published: October 08, 2025

Filters

Long-term Outcome of Anti-VEGF Treatment in Retinopathy of Prematurity: A 12-Year Follow-Up with Ultra-Widefield Imaging.

Long-term Outcome of Anti-VEGF Treatment in Retinopathy of Prematurity: A 12-Year Follow-Up with Ultra-Widefield Imaging.

DERIVATION OF A SHORT FORM OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

DERIVATION OF A SHORT FORM OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Characterization of collateral circulation after anti-VEGF treatment for retinal vein occlusion

Characterization of collateral circulation after anti-VEGF treatment for retinal vein occlusion

Trends in Anti-Vascular Endothelial Growth Factor Injections Among Medicare Part B Beneficiaries in 2013-2021 and the Step Therapy Era.

Trends in Anti-Vascular Endothelial Growth Factor Injections Among Medicare Part B Beneficiaries in 2013-2021 and the Step Therapy Era.

Fibrosis in Patients With Choroidal Neovascularization Based on Spectral-Domain Optical Coherence Tomography: Findings From the HARBOR Trial.

Fibrosis in Patients With Choroidal Neovascularization Based on Spectral-Domain Optical Coherence Tomography: Findings From the HARBOR Trial.

Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice.

Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice.

Clinical Challenges with Neovascular Glaucoma-Patient Tailored Strategies and Outcomes.

Clinical Challenges with Neovascular Glaucoma-Patient Tailored Strategies and Outcomes.

Short-Term Effects of Intravitreal Ranibizumab Biosimilar Injections in Patients with Neovascular Age-Related Macular Degeneration on Retinal Nerve Fiber Layer Thickness.

Short-Term Effects of Intravitreal Ranibizumab Biosimilar Injections in Patients with Neovascular Age-Related Macular Degeneration on Retinal Nerve Fiber Layer Thickness.

A Multicentre Study of Presumed Post Anti Vascular Endothelial Growth Factor Injection Endophthalmitis in Infants with Retinopathy of Prematurity: Clinical Features, Treatment Outcomes, and Review of Literature.

A Multicentre Study of Presumed Post Anti Vascular Endothelial Growth Factor Injection Endophthalmitis in Infants with Retinopathy of Prematurity: Clinical Features, Treatment Outcomes, and Review of Literature.

Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk.

Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk.

Cost-effectiveness analysis of Brolucizumab compared to Aflibercept and Ranibizumab in nAMD with persistent retinal fluid.

Cost-effectiveness analysis of Brolucizumab compared to Aflibercept and Ranibizumab in nAMD with persistent retinal fluid.

Model-based pharmacoeconomic analysis of anti-VEGF strategies for neovascular age-related macular degeneration: a value-based comparison of real-world administration approaches.

Model-based pharmacoeconomic analysis of anti-VEGF strategies for neovascular age-related macular degeneration: a value-based comparison of real-world administration approaches.